The effects of mTOR-Akt interactions on anti-apoptotic signaling in vascular endothelial cells

Olivier Dormond1, Joren C Madsen, David M Briscoe

  • 1Transplant Research Center, Division of Nephrology, Department of Medicine, Children's Hospital, Boston, Massachusetts 02115, USA.

Insights

The mechanistic target of rapamycin (mTOR) pathway regulates Akt activation in endothelial cells, suppressing pro-survival signals and promoting apoptosis when inhibited.

Area of Science:

  • Endothelial cell biology
  • Molecular signaling pathways
  • Cellular apoptosis

Background:

  • The mechanistic target of rapamycin (mTOR) pathway is known to activate the protein kinase Akt in various cell types.
  • The specific association between mTOR and Akt in vascular endothelial cells remains largely uncharacterized.
  • The functional importance of mTOR/Akt signaling within the endothelium has not been elucidated.

Purpose of the Study:

  • To investigate the role of mTOR in regulating Akt activation within endothelial cells.
  • To determine the functional consequences of mTOR/Akt signaling inhibition on endothelial cell survival.

Main Methods:

  • Endothelial cells were treated with the mTOR inhibitor rapamycin.
  • Akt phosphorylation and activity were assessed using its substrate, glycogen synthase kinase-3.
  • Experiments involved endothelial cells transfected with a rapamycin-resistant mTOR construct.
  • The impact of rapamycin on growth factor- and insulin-induced Akt phosphorylation was examined.
  • Phosphorylation and inactivation of Akt substrates Foxo1 and Foxo3a were analyzed.
  • Endothelial cell apoptosis was quantified following serum withdrawal or stimulation with vascular endothelial growth factor (VEGF) or tumor necrosis factor (TNF).

Main Results:

  • Rapamycin treatment decreased Akt phosphorylation and activity in endothelial cells.
  • This effect was dependent on mTOR, as rapamycin did not inhibit Akt in cells with resistant mTOR.
  • Rapamycin blocked Akt phosphorylation induced by VEGF, TNF, and insulin.
  • Rapamycin inhibited VEGF- and Akt-inducible phosphorylation of pro-apoptotic factors Foxo1 and Foxo3a.
  • Inhibition of Akt activity by rapamycin increased endothelial cell apoptosis under various conditions.

Conclusions:

  • mTOR plays a critical role in regulating Akt phosphorylation and activation in vascular endothelial cells.
  • Inhibition of mTOR in endothelial cells suppresses Akt-mediated pro-survival signals.
  • These findings highlight the significance of the mTOR/Akt pathway in maintaining endothelial cell viability.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...